
PTCT
PTC Therapeutics Inc.
$49.33
-$0.46(-0.92%)
56
Overall
60
Value
60
Tech
50
Quality
Market Cap
$3.93B
Volume
906.92K
52W Range
$30.41 - $58.38
Target Price
$66.69
Order:
Income Statement
Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||
Total Revenue | $36.8M | $82.7M | $194.4M | $264.7M | $307.0M | $380.8M | $538.6M | $698.8M | $937.8M | $806.8M | ||
Total Revenue | $33.7M | $81.4M | $194.4M | $264.7M | $307.0M | $380.8M | $538.6M | $698.8M | $937.8M | $806.8M | ||
COST OF GOODS SOLD | ||||||||||||
Cost of Revenue | -- | -- | $-4.6M | $-12.7M | $400.0K | $18.9M | $32.3M | $44.7M | $65.5M | $57.4M | ||
GROSS PROFIT | ||||||||||||
Gross Profit | $36.8M | $82.7M | $-4.6M | $-12.7M | $307.0M | $361.8M | $506.3M | $654.1M | $937.8M | $749.4M | ||
OPERATING EXPENSES | ||||||||||||
Operating Expenses | $-203.9M | $-214.8M | $-258.7M | $-380.4M | $548.1M | $812.5M | $913.0M | $1.1B | $1.4B | $1.1B | ||
Research & Development | $121.8M | $117.6M | $117.5M | $172.0M | $257.5M | $477.6M | $540.7M | $651.5M | $666.6M | $534.5M | ||
Research Expense | $121.8M | $117.6M | $117.5M | $172.0M | $257.5M | $477.6M | $540.7M | $651.5M | $666.6M | $534.5M | ||
Selling, General & Administrative | $82.1M | $97.1M | $121.3M | $153.5M | $202.5M | $245.2M | $285.8M | $326.0M | $332.5M | $300.9M | ||
Selling & Marketing Expenses | -- | -- | $121.3M | $153.5M | $202.5M | $245.2M | $285.8M | -- | -- | -- | ||
General & Administrative Expenses | $82.1M | $97.1M | $-2.2M | $-2.7M | $202.5M | $245.2M | $285.8M | $326.0M | $332.5M | $300.9M | ||
Salaries & Wages | $-34.0M | $-35.0M | $-30.6M | $-33.3M | $-42.1M | $-70.3M | $-103.5M | -- | -- | -- | ||
Depreciation & Amortization | $-2.9M | $-3.3M | $15.4M | $22.9M | $27.6M | $36.9M | $54.8M | $116.6M | $222.6M | $60.7M | ||
Depreciation & Amortization | $-2.9M | $-3.3M | $15.4M | $22.9M | $27.6M | $36.9M | $54.8M | $116.6M | $222.6M | $60.7M | ||
Amortization | $-107.0K | $-302.0K | $15.4M | $22.9M | $27.6M | $36.9M | $54.8M | $116.6M | $222.6M | $60.7M | ||
Other Operating Expenses | $-203.9M | $-214.8M | $-258.7M | $-380.4M | $-12.1M | $-29.6M | $-32.3M | $-44.7M | -- | -- | ||
OPERATING INCOME | ||||||||||||
Operating income | $-167.1M | $-132.1M | $-258.7M | $-361.1M | $-241.2M | $-431.8M | $-374.4M | $-447.4M | $-439.5M | $-302.6M | ||
EBITDA | $-164.5M | $-136.1M | $-59.0M | $-101.9M | $-205.3M | $-303.1M | $-368.2M | $-356.0M | $-447.8M | $-278.5M | ||
NON-OPERATING ITEMS | ||||||||||||
Interest Expense (Non-Operating) | -- | -- | -- | -- | -- | $56.4M | $86.0M | $90.9M | $129.2M | -- | ||
Intinc | $-2.4M | $-8.3M | $-12.1M | $-12.6M | $-12.5M | $-56.4M | $-86.0M | $-90.9M | $-129.2M | $-167.0M | ||
Net Non-Operating Interest Income/Expense | $-2.4M | $-8.3M | $-12.1M | $-12.6M | $-12.5M | $-56.4M | $-86.0M | $-90.9M | $-129.2M | $-167.0M | ||
Gain on Sale of Securities | -- | -- | -- | -- | $2.2M | $700.0K | $800.0K | $4.0M | -- | -- | ||
Other Income/Expense | $465.0K | $1.2M | $-193.1M | $-245.5M | $34.6M | $-61.9M | $57.4M | $-56.7M | $217.5M | $148.5M | ||
Other Special Charges | $-465.0K | $-1.2M | $193.1M | $264.9M | $13.7M | $85.2M | $-57.9M | $-49.2M | $-127.4M | $6.5M | ||
SPECIAL ITEMS | ||||||||||||
Special Income Charges | -- | -- | $6.8M | $7.5M | -- | -- | -- | -- | -- | -- | ||
Other Impairment Of Capital Assets | -- | -- | -- | -- | -- | -- | -- | $33.4M | $217.8M | $159.5M | ||
PRE-TAX INCOME | ||||||||||||
EBIT | $-170.0M | $-141.5M | $-77.7M | $-128.1M | $-239.9M | $-346.6M | $-432.3M | $-496.6M | $-696.1M | $-363.1M | ||
Pre-Tax Income | $-170.0M | $-141.5M | $-77.7M | $-128.1M | $-239.9M | $-402.9M | $-518.3M | $-587.5M | $-696.1M | $-363.1M | ||
INCOME TAX | ||||||||||||
Tax Provision | $485.0K | $569.0K | $1.3M | $-29.0K | $11.7M | $35.2M | $5.6M | $-28.5M | $-69.5M | $176.0K | ||
NET INCOME | ||||||||||||
Net Income | $-170.4M | $-142.1M | $-79.0M | $-128.1M | $-251.6M | $-438.2M | $-523.9M | $-559.0M | $-626.6M | $-363.3M | ||
Net Income (Continuing Operations) | $-170.4M | $-142.1M | $-79.0M | $-128.1M | $-251.6M | $-438.2M | $-523.9M | $-559.0M | $-626.6M | $-363.3M | ||
Net Income (Discontinued Operations) | $-170.4M | $-142.1M | $-79.0M | $-128.1M | $-251.6M | $-438.2M | $-523.9M | $-559.0M | $-626.6M | $-363.3M | ||
Net Income (Common Stockholders) | $-170.4M | $-142.1M | $-79.0M | $-128.1M | $-227.3M | $-379.1M | $-459.2M | $-559.0M | $-626.6M | $-363.3M | ||
TOTALS | ||||||||||||
Total Expenses | $-203.9M | $-214.8M | $-263.3M | $-393.1M | $548.5M | $813.0M | $915.2M | $1.1B | $1.4B | $1.2B | ||
SHARE & EPS DATA | ||||||||||||
Average Shares Outstanding | $33.6M | $34.0M | $39.2M | $46.6M | $58.9M | $66.0M | $70.5M | $71.7M | $74.8M | $76.8M | ||
Average Shares Outstanding (Diluted) | $33.6M | $34.1M | $39.1M | $46.6M | $58.9M | $66.0M | $70.5M | $71.7M | $74.8M | $76.8M | ||
Shares Outstanding | $34.3M | $34.6M | $41.8M | $58.4M | $62.6M | $70.3M | $71.4M | $73.8M | $76.6M | $78.9M | ||
Basic EPS | -- | -- | -- | $-2.75 | $-4.27 | -- | $-7.43 | $-7.79 | $-8.37 | $-4.73 | ||
Basic EPS (Continuing Operations) | -- | -- | -- | -- | -- | -- | -- | $-7.79 | $-8.37 | $-4.73 | ||
Diluted EPS | $-5.07 | $-4.17 | $-2.02 | $-2.75 | $-4.27 | $-6.64 | $-7.43 | $-7.79 | $-8.37 | $-4.73 | ||
Diluted EPS (Continuing Operations) | -- | -- | -- | -- | -- | -- | -- | $-7.79 | $-8.37 | $-4.73 | ||
OTHER METRICS | ||||||||||||
Gain On Sale Of P P E | -- | -- | $-5.0K | $-2.0K | -- | -- | -- | -- | -- | -- | ||
Other Gand A | $82.1M | $97.1M | $-2.2M | $-2.7M | $202.5M | $245.2M | $285.8M | $326.0M | $332.5M | $300.9M | ||
Rent And Landing Fees | $82.1M | $97.1M | $121.3M | -- | -- | -- | -- | -- | -- | -- | ||
Selling Expense | -- | -- | $121.3M | $153.5M | $202.5M | $245.2M | $285.8M | -- | -- | -- | ||
Othspecchg | -- | -- | $-6.8M | $-7.5M | -- | -- | -- | -- | -- | -- |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | PTCT | $49.33 | -0.9% | 906.92K |
3 | ||||
4 | ||||
5 | ||||
6 |